Orbimed Advisors LLC Portfolio Holdings

Orbimed Advisors LLC

  • $3.21 Billion
  • Q1 2025

Orbimed Advisors LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $3.21 Billion distributed in 111 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Edgewise Therapeutics, Inc. with a value of $330M, Boston Scientific Corp with a value of $284M, Eli Lilly & CO with a value of $279M, Intuitive Surgical Inc with a value of $144M, and Stryker Corp with a value of $134M.

Examining the 13F form we can see an decrease of $483M in the current position value, from $3.69B to 3.21B.

Orbimed Advisors LLC is based out at San Diego, CA

Below you can find more details about Orbimed Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $3.21 Billion
Healthcare: $3.2 Billion
ETFs: $8.11 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$239M
$42.5 Million 1.32% of portfolio
22,362,850
Q4 2022 Added 1.83%
$270M
$41.9 Million 1.3% of portfolio
3,406,335
Q2 2024 Reduced 14.93%
$64.9M
$34.4 Million 1.07% of portfolio
73,114,592
Q3 2022 Added 0.23%
$183M
$22.1 Million 0.69% of portfolio
6,943,654
Q3 2021 Reduced 13.78%
$147M
$20.9 Million 0.65% of portfolio
7,562,971
Q3 2024 Reduced 0.74%
$210M
$20.1 Million 0.63% of portfolio
5,779,071
Q3 2022 New
$244M
$16 Million 0.5% of portfolio
13,135,260
Q4 2024 New
$111M
$15.9 Million 0.5% of portfolio
6,059,528
Q3 2024 Added 8.99%
$75.8M
$10.9 Million 0.34% of portfolio
6,830,300
Q1 2025 Added 56.02%
$262M
$8.42 Million 0.26% of portfolio
5,968,451
Q4 2024 Added 31.64%
$50M
$4.53 Million 0.14% of portfolio
3,539,358
Q4 2023 Added 11.09%
$60.8M
$3.29 Million 0.1% of portfolio
3,322,488
Q3 2021 Reduced 3.03%
$162M
$1.8 Million 0.06% of portfolio
573,884
Q1 2025 Reduced 62.7%
$88.6M
$1.51 Million 0.05% of portfolio
821,400
Q4 2024 Reduced 44.52%
$188M
$1.63 Million 0.05% of portfolio
6,776,515
Q1 2025 Reduced 5.0%
$300M
$1.23 Million 0.04% of portfolio
348,000
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 111
  • Current Value $3.21 Billion
  • Prior Value $3.69 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 11 stocks
  • Additional Purchases 15 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 22 stocks
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email